- Home
- Automated
- List of product information
- VITALIPID N INFANT INJECTION [SIN05207P]
VITALIPID N INFANT INJECTION [SIN05207P]
Active ingredients: VITALIPID N INFANT INJECTION
Last updated 26 October 2025
On this page
Product Info
VITALIPID N INFANT INJECTION
[SIN05207P]
Product information
Active Ingredient and Strength | VITAMIN A - 230 INTERNATIONAL UNITS/ML |
Dosage Form | INJECTION |
Manufacturer and Country | FRESENIUS KABI AB - SWEDEN |
Registration Number | SIN05207P |
Licence Holder | FRESENIUS KABI (SINGAPORE) PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | B05XC |
Indications
Vitalipid N Infant is indicated in infants and children up to 11 years of age as a supplement in complete intravenous nutrition to meet the daily requirements of the fat soluble vitamins A, D2, E and K1.
Dosage
Must be diluted before use
Preterms and Infants below 2.5 kg
Vitalipid N Infant in a dosage of 4 ml/kg bodyweight/day.
Infants and children above 2.5 kg and under 11 years.
Vitalipid N Infant in a dosage of 10 ml/day. The daily dosage must not exceed 10 ml.
The daily dosage is added to Intralipid 10% or 20%. After mixing by gentle agitation the emulsion is infused as described for Intralipid. The daily maintenance dosages of the vitamins A, D2, E and K1 are thereby supplied.
Vitalipid N Infant should be added aseptically within one hour before the start of the infusion and should be used within 24 hours.
Contraindications
Known hypersensitivity to egg-, soya- or peanut protein or to any of the active substances or excipients.